ACE-031 Research Peptide | Biovantage Labs

ACE-031 Research Peptide | Biovantage Labs

ACE-031 is a soluble form of activin receptor type IIB (ACVR2B) fused to an IgG1 Fc domain, studied as a myostatin and GDF ligand trap in skeletal muscle mass research models. Biovantage Labs supplies ACE-031 at 99+% purity, HPLC/MS verified. Domestically fulfilled from Canada. Not for human consumption.

$150.00

Description

ACE-031 Biovantage Labs Research Peptide

ACE-031 is a soluble form of activin receptor type IIB (ACVR2B) fused to an IgG1 Fc domain, studied as a myostatin and GDF ligand trap in skeletal muscle mass research models. Biovantage Labs supplies ACE-031 at 99+% purity, HPLC/MS verified. Domestically fulfilled from Canada. Not for human consumption. Biovantage Labs provides this compound at 99+% purity, confirmed by batch-specific HPLC and Mass Spectrometry analysis, as a lyophilized compound for use in controlled laboratory settings.

Molecular Profile and Chemical Specifications

Specification Detail
Classification ACVR2B-Fc fusion protein – TGF-beta ligand trap
Purity ≥99+% (HPLC/MS verified)
Physical Form Lyophilized white powder

 

Primary Research Mechanisms

ACE-031 and Follistatin-344 are studied in the same skeletal muscle hypertrophy research context but through structurally distinct mechanisms. ACE-031, as a decoy receptor-Fc fusion, sequesters multiple TGF-beta ligands through a receptor binding approach, and Follistatin-344, as a secreted glycoprotein, binds the same ligands through direct protein-protein interaction. Comparative research between the two tools examines whether the mechanism of antagonism influences research outcomes independently of the degree of pathway blockade.

Broad TGF-beta Ligand Sequestration

ACE-031’s ACVR2B domain binds multiple TGF-beta superfamily ligands including myostatin (GDF-8), activin A/B, GDF-11, and BMP-9 preventing their engagement with endogenous receptors. This broad ligand trap activity is studied in muscle wasting and atrophy research models.

Skeletal Muscle Mass and Fibre Type Research

ACVR2B-mediated TGF-beta signalling suppresses muscle anabolism via SMAD2/3. Research using ACE-031 examines the consequences of broad ligand sequestration on muscle fibre cross-sectional area, fibre type composition, and functional strength outcomes in animal models.

Comparison with Myostatin-Specific Inhibition

ACE-031’s multi-ligand activity profile distinguishes it from myostatin-specific inhibitors. Research comparing ACE-031 with myostatin-selective approaches investigates the additive or synergistic contributions of activin and GDF-11 blockade beyond isolated myostatin inhibition.

For research examining dual-pathway skeletal muscle anabolism, IGF-1 LR3 represents the complementary anabolic research axis, promoting muscle satellite cell proliferation and PI3K-Akt-mTOR signalling through IGF-1 receptor engagement, in contrast to ACE-031’s TGF-beta ligand sequestration approach.

Reconstitution Protocol

  • Reconstitute using sterile bacteriostatic water or 0.9% sodium chloride solution
  • Introduce diluent slowly along the interior vial wall do not inject directly onto the lyophilized cake
  • Swirl gently until fully dissolved do not shake or vortex
  • Allow the vial to equilibrate to room temperature before opening to prevent condensation

Storage and Stability

Storage Condition State Estimated Stability
-20°C to -80°C Lyophilized 24+ months
2°C to 8°C Lyophilized 12 months
Room temperature (20°C) Lyophilized 3 months
2°C to 8°C Reconstituted 7 to 14 days

 

Store in a desiccated environment away from UV exposure. Avoid repeated freeze-thaw cycles, which degrade peptide chain integrity over time.

ACE-031 Research FAQ

Q: How does ACE-031 differ from Follistatin-344 as a myostatin antagonist?

A: Follistatin-344 is a secreted glycoprotein that binds activins and myostatin through direct protein-protein interaction. ACE-031 is a biologically engineered receptor-Fc fusion that sequesters the same ligands through a decoy receptor mechanism. Both result in reduced ACVR2B signalling but via distinct structural approaches, making them complementary research tools.

Q: Is ACE-031 for human use?

A: No. ACE-031 supplied by Biovantage Labs is strictly for laboratory research purposes. It is not approved for human consumption, veterinary use, or clinical application.

Q: What purity standard does Biovantage Labs apply?

A: Every batch is verified at 99+% purity using HPLC to confirm compound concentration and Mass Spectrometry to confirm molecular identity. Batch-specific COA documentation is available upon request.

Q: Where does Biovantage Labs ship from?

A: All Biovantage Labs products are fulfilled domestically from within Canada, eliminating customs clearance risk and reducing transit time compared to international suppliers.

 

Reviews

There are no reviews yet.

Be the first to review “ACE-031 Research Peptide | Biovantage Labs”

Your email address will not be published. Required fields are marked *

Related Products

High Quality Research Peptides You Can Trust

Explore premium-grade peptides for scientific research, purity tested, lab certified, and shipped discreetly.